Clinical Trial Update: iSITE: Investigation of Somatic Alterations in Tumours of the Eye

View source ↗

Summary

The iSITE trial from The Wellcome Sanger Institute investigates somatic alterations in ocular melanoma and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Melanoma

Snippet

Sponsor: The Wellcome Sanger Institute | Conditions: Somatic Mutation, Ocular Melanoma | Status: COMPLETED